NCT05404347 NGS in Gallbladder Cancer and Response to Treatment
| NCT ID | NCT05404347 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Banaras Hindu University |
| Condition | Gallbladder Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2018-01-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2018-01-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Evidence suggests distinct models of molecular and pathologic progression, and a growing body of genetics data points to a heterogeneous collection of underlying mutations in key oncogenes and tumor suppressor genes. Although tumor genetics have been used to tailor individual treatment regimens and guide clinical decision making in other cancers, these principles have not been applied in gallbladder malignancy. Recent clinical trials with targeted therapies seem promising, although the relationships between subsets of patients with positive responses to therapy and tumor genetics remain unexplored.
Eligibility Criteria
Inclusion Criteria: * Treatment naïve patients with histologically proven carcinoma of the gallbladder. Exclusion Criteria: * No histological evidence of malignancy * Pregnant and lactating women
Contact & Investigator
Manoj Pandey, Ms, PhD
PRINCIPAL INVESTIGATOR
Banaras Hindu University
Frequently Asked Questions
Who can join the NCT05404347 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Gallbladder Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05404347 currently recruiting?
Yes, NCT05404347 is actively recruiting participants. Contact the research team at mpandey66@bhu.ac.in for enrollment information.
Where is the NCT05404347 trial being conducted?
This trial is being conducted at Varanasi, India.
Who is sponsoring the NCT05404347 clinical trial?
NCT05404347 is sponsored by Banaras Hindu University. The principal investigator is Manoj Pandey, Ms, PhD at Banaras Hindu University. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.